Table 2.
Results of Cox proportional hazards regression analyses for new cardiovascular events in convalescent period.
| Cardiovascular events | Number | Number of the event | Event rate | Multivariate adjusted HR (95% CI)a |
|---|---|---|---|---|
| Any cardiovascular event | ||||
| Patients with SARS-CoV-2 infection | 10,691 | 618 | 5.8% | 0.90 (0.80–1.02) |
| Patients without SARS-CoV-2 infection | 10,691 | 756 | 7.1% | Reference |
| Ischemic heart disease or stroke event | ||||
| Patients with SARS-CoV-2 infection | 10,691 | 594 | 5.6% | 0.93 (0.82–1.04) |
| Patients without SARS-CoV-2 infection | 10,691 | 716 | 6.7% | Reference |
| Ischemic heart disease | ||||
| Patients with SARS-CoV-2 infection | 10,691 | 411 | 3.8% | 1.00 (0.87–1.15) |
| Patients without SARS-CoV-2 infection | 10,691 | 482 | 4.5% | Reference |
| Ischemic stroke | ||||
| Patients with SARS-CoV-2 infection | 10,691 | 219 | 2.0% | 0.84 (0.70–1.02) |
| Patients without SARS-CoV-2 infection | 10,691 | 268 | 2.5% | Reference |
| Intracerebral or subarachnoid hemorrhage | ||||
| Patients with SARS-CoV-2 infection | 10,691 | 29 | 0.3% | 0.42 (0.26–0.69) |
| Patients without SARS-CoV-2 infection | 10,691 | 56 | 0.5% | Reference |
SARS-CoV-2: severe acute respiratory syndrome coronavirus 2; HR: hazard ratio; CI: confidence interval.
a
See the “Methods” section for variables adjusted in multivariate model.